Yifan Pang
Hematology | Oncology
1021 Morehead Medical Drive
Building 2, Suite 60201
Charlotte, NC 28204
Building 2, Suite 60201
Charlotte, NC 28204
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.
Journal: American journal of hematology
Published: March 25, 2026
Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: April 29, 2024
Utilizing big data and artificial intelligence to improve the cross-border trade english education.
Journal: PloS one
Published: March 20, 2024
Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma.
Journal: Frontiers in oncology
Published: March 05, 2024
Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia.
Journal: Best practice & research. Clinical haematology
Published: April 23, 2023
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience.
Journal: Transplantation proceedings
Published: July 14, 2022
A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease.
Journal: Blood advances
Published: June 28, 2022
The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.
Journal: Blood advances
Published: December 27, 2021
Last Updated: 09/26/2026